Entries by

All BioGX COVID-19 tests have coverage for new strains of SARS-CoV-2

During the course of the SARS-CoV-2 pandemic the virus has accumulated a number of mutations in its genome, causing concern not only for whether the mutations might affect vaccine effectiveness, but also for diagnostic test detection of emerging strain variants.  Most recently, a number of reports have hypothesized that strains from the B.1.1.7 lineage of […]

BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19

World’s Simplest High-Throughput RT-PCR Test for COVID-19 has the potential to increase testing capacity by millions per week Birmingham, AL, October 12, 2020 – BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of […]

Fully-Automated Workflow for COVID-19 & Winter Virus Testing

The BioGX multiplex COVID-19, Flu A, Flu B and RSV test is intended for the qualitative detection of RNA specific to SARS-CoV-2,  Influenza A, Influenza B, and Respiratory Syncytial Virus A/B that may be present in Pharyngeal and Nasopharyngeal swab collections in transport media and saline, obtained from individuals at risk of respiratory viral infections. […]

BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System

Amsterdam, The Netherlands, 29 September 2020 – BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a patient sample using the BD MAX™ System.   The test is offered in BioGX’s trusted, easy […]

BioGX: Expanding to help protect people around the world

The American MedTech firm BioGX is supplying coronavirus test kits worldwide from its global office and lab in Amsterdam Science Park. “Everyone is coming together to help, they recognise the importance of mass testing,” CEO Dr Shazi Iqbal explains to I amsterdam how the company is working to fight the global coronavirus outbreak. Full article […]

Combat the spread of infectious disease 

The past few months has shown that a team’s rapid response to expediting an assay globally, dedicated  to the detection of SARS-CoV-2, is possible. BioGX, in a long-term partnership with Becton, Dickinson  and Company, has submitted a test to the FDA for emergency use authorisation (EUA) in the US, in  parallel to CE-IVD approval. In […]